{
    "eid": "2-s2.0-84907876423",
    "title": "Targeting the inflammatory pathway as a therapeutic tool for major depression",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Endocrine and Autonomic Systems",
            "@code": "2807"
        },
        {
            "$": "Neurology",
            "@code": "2808"
        },
        {
            "$": "Endocrinology",
            "@code": "1310"
        },
        {
            "$": "Immunology",
            "@code": "2403"
        }
    ],
    "keywords": [
        "Cytokines",
        "Depression",
        "Inflammation"
    ],
    "authors": [
        "Cristiano Noto"
    ],
    "citedby-count": 36,
    "ref-count": 97,
    "ref-list": [
        "Immune disturbances during major depression: Upregulated expression of interleukin-2 receptors",
        "Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression",
        "Evidence for an immune response in major depression: A review and hypothesis",
        "Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder",
        "IL-10 modulates depressive-like behavior",
        "Cytokines mediated inflammation and decreased neurogenesis in animal models of depression",
        "A Meta-Analysis of Cytokines in Major Depression",
        "Major depression and activation of the inflammatory response system",
        "The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection",
        "The relationship of depression and stressors to immunological assays: A meta-analytic review",
        "Immunological differences between patients with major depression and somatization syndrome",
        "Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression",
        "Associations of depression with c-reactive protein, IL-1, and IL-6: A meta-analysis",
        "Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression",
        "Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways",
        "Cytokine-induced sickness behavior: Mechanisms and implications",
        "From inflammation to sickness and depression: When the immune system subjugates the brain",
        "TNF-\u03b1 as a molecular target in bipolar disorder",
        "Behavioral effects of infection with IL-6 adenovector",
        "Behavioral effects of infection with interferon-gamma adenovector",
        "In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression",
        "A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness",
        "Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression",
        "A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity",
        "Prevalence of depression in survivors of acute myocardial infarction: Review of the evidence",
        "Depression as a predictor for coronary heart disease: A review and meta-analysis",
        "Depression after myocardial infarction: TNF-\u03b1-induced alterations of the blood-brain barrier and its putative therapeutic implications",
        "Psychological stress activates interleukin-1\u03b2 gene expression in human mononuclear cells",
        "Synergistic relationships among stress, depression, and troubled relationships: Insights from psychoneuroimmunology",
        "Close relationships, inflammation, and health",
        "Impact of childhood stress on psychopathology",
        "Elevated inflammation levels in depressed adults with a history of childhood maltreatment",
        "Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression",
        "New drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors",
        "Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors",
        "The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications",
        "Interleukin-6 and verbal memory in recurrent major depressive disorder",
        "TNF\u03b1 potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: Neuroprotection by NF\u03baB inhibition",
        "Neurotoxic consequences of central long-term administration of interleukin-2 in rats",
        "Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)- stimulated microglial cells",
        "Inhibitory effects of SSRIs on IFN-\u03b3 induced microglial activation through the regulation of intracellular calcium",
        "Tricyclic antidepressants inhibit IL-6, IL-1\u03b2 and TNF-\u03b1 release in human blood monocytes and IL-2 and interferon-\u03b3 in T cells",
        "Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration",
        "The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: A meta-analysis",
        "Das Sauerstoff-Bed\u00fc Rfniss des Organismus: Eine Farbenanalytische Studie",
        "Inflammatory cell trafficking across the blood-brain barrier: Chemokine regulation and in vitro models",
        "Immune system to brain signaling: Neuropsychopharmacological implications",
        "Comparison of saturable transport and extracellular pathways in the passage of interleukin-1\u03b1 across the blood-brain barrier",
        "Passage of cytokines across the blood-brain barrier",
        "Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication",
        "T-cell trafficking in the central nervous system",
        "Interleukin-1B promoter (-31T/C and -511C/T) polymorphisms in paranoid schizophrenia.",
        "Poor replication of candidate genes for major depressive disorder using genome-wide association data",
        "Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample",
        "Promoter variants in IL18 are associated with onset of depression in patients previously exposed to stressful-life events",
        "Cytokine production and treatment response in major depressive disorder",
        "Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds",
        "Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness",
        "Psychoneuroimmunology meets neuropsychopharmacology: Translational implications of the impact of inflammation on behavior",
        "Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.",
        "Causal relationship between stressful life events and the onset of major depression",
        "Is depression an inflammatory disorder?",
        "Depressive symptoms and change in abdominal obesity in older persons",
        "Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies",
        "Epidemic inflammation: Pondering obesity",
        "Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression",
        "The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine",
        "Clinical trial of adjunctive celecoxib treatment in patients with major depression: A double blind and placebo controlled trial",
        "Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial",
        "Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment",
        "Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia",
        "Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: Findings from a randomized controlled trial",
        "Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: A pilot open-label study",
        "Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients",
        "Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks [7]",
        "Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial",
        "A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers",
        "Novel therapeutic targets in depression: Minocycline as a candidate treatment",
        "Is there a role for curcumin in the treatment of bipolar disorder?",
        "N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individuals"
    ],
    "affiliation": [
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Universidade Federal de S\u00e3o Paulo",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "affilname": "Deakin University",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "affilname": "University Health Network",
            "affiliation-country": "Canada"
        }
    ],
    "funding": [
        "National Institute of Mental Health"
    ]
}